ABTAbbott Laboratories
Healthcare · Medical DevicesNYSEStockMkt cap $184.3B
Disclosed trades
185
0 in 30d · 4 in 90d
Politicians
38
Last trade Oct 2, 2026
Buys
86
$1.1M at range midpoints
Sells
97
$1.7M at range midpoints
Closing price · 365 days
Nov 6, 2025 – Nov 5, 2026
Monthly buys vs sells · 24 months
Counts of disclosed transactions
- Buys
- Sells (incl. partial)
Politicians who traded it
17 hold it now Estimated
| Politician | Seat | Trades | Buys | Sells | Bought (mid) | Sold (mid) | Last trade | Est. position Estimated |
|---|---|---|---|---|---|---|---|---|
| DRo Khanna | House · CA-17 | 76 | 31 | 44 | $444K | $747.5K | Sep 4, 2026 | $116.2K |
| DJosh Gottheimer | House · NJ-05 | 9 | 5 | 4 | $40K | $32K | May 27, 2026 | $13.3K |
| DKathy E. Manning | House · NC-06 | 9 | 7 | 2 | $56K | $16K | Jul 2, 2024 | $43K |
| DGilbert Ray Cisneros, Jr. | House · CA-31 | 7 | 4 | 3 | $32K | $24K | Sep 18, 2026 | $18.9K |
| DDean Phillips | House · MN-03 | 6 | 6 | 0 | $48K | $0 | Jan 5, 2021 | $40.3K |
| RRichard McCormick | House · GA-07 | 6 | 5 | 1 | $40K | $8K | Jul 30, 2026 | $37.1K |
| DJared Moskowitz | House · FL-23 | 5 | 1 | 4 | $8K | $32K | Jan 15, 2025 | — |
| RThomas H. Kean, Jr. | House · NJ-07 | 5 | 4 | 1 | $32K | $8K | Sep 17, 2026 | $23.8K |
| RByron Donalds | House · FL-19 | 4 | 2 | 2 | $16K | $16K | Dec 4, 2025 | — |
| RJohn R. Curtis | Senate · UT | 4 | 2 | 2 | $16K | $16K | Dec 4, 2023 | $2.8K |
| DJulie Johnson | House · TX-32 | 4 | 0 | 4 | $0 | $32K | May 12, 2026 | — |
| DKatherine M. Clark | House · MA-05 | 4 | 2 | 2 | $16K | $16K | Nov 10, 2020 | $396 |
| RRick W. Allen | House · GA-12 | 4 | 2 | 2 | $65K | $65K | Jul 14, 2026 | — |
| RRobert J. Wittman | House · VA-01 | 4 | 2 | 2 | $16K | $16K | Jul 15, 2022 | $8.4K |
| RDavid B. McKinley | House · WV-01 | 3 | 1 | 2 | $8K | $16K | Sep 21, 2022 | — |
| RMichael T. McCaul | House · TX-10 | 3 | 1 | 2 | $32.5K | $40.5K | Mar 4, 2026 | — |
| DRick Larsen | House · WA-02 | 3 | 1 | 2 | $8K | $16K | Jul 8, 2026 | — |
| RBruce Westerman | House · AR-04 | 2 | 1 | 1 | $8K | $8K | Apr 21, 2025 | — |
| RCarol D. Miller | House · WV-01 | 2 | 2 | 0 | $40.5K | $0 | Mar 4, 2021 | $44.8K |
| DGreg Stanton | House · AZ-04 | 2 | 1 | 1 | $8K | $8K | Oct 24, 2023 | — |
| DJoe Courtney | House · CT-02 | 2 | 1 | 1 | $8K | $8K | Aug 7, 2020 | $1.5K |
| RJohn James | House · MI-10 | 2 | 1 | 1 | $8K | $8K | Sep 4, 2024 | $1.7K |
| RJulia Letlow | House · LA-05 | 2 | 1 | 1 | $8K | $8K | Dec 8, 2025 | $323 |
| RK. Michael Conaway | House · TX-11 | 2 | 2 | 0 | $107.5K | $0 | Sep 28, 2020 | $116.9K |
| RLisa C. McClain | House · MI-09 | 2 | 1 | 1 | $8K | $8K | Jul 10, 2025 | — |
| RMichael C. Burgess | House · TX-26 | 2 | 1 | 1 | $8K | $8K | Jan 7, 2022 | $375 |
| RShelley Moore Capito | Senate · WV | 2 | 1 | 1 | $8K | $8K | Feb 24, 2025 | $4.9K |
| RAlan Armstrong | Senate · OK | 1 | 0 | 1 | $0 | $32.5K | Mar 27, 2026 | — |
| DDaniel S. Goldman | House · NY-10 | 1 | 0 | 1 | $0 | $75K | Mar 6, 2023 | — |
| DEmily Randall | House · WA-06 | 1 | 0 | 1 | $0 | $8K | Jan 6, 2025 | — |
| RJefferson Shreve | House · IN-06 | 1 | 0 | 1 | $0 | $75K | May 12, 2025 | — |
| DKim Schrier | House · WA-08 | 1 | 0 | 1 | $0 | $8K | Oct 28, 2021 | — |
| DLaura Friedman | House · CA-30 | 1 | 0 | 0 | $0 | $0 | Mar 24, 2026 | — |
| RMike Kelly | House · PA-16 | 1 | 0 | 1 | $0 | $8K | Jul 17, 2026 | — |
| DMikie Sherrill | House · NJ-11 | 1 | 0 | 1 | $0 | $8K | Feb 20, 2020 | — |
| RPete Ricketts | Senate · NE | 1 | 0 | 1 | $0 | $175K | Sep 21, 2023 | — |
| RPete Sessions | House · TX-17 | 1 | 0 | 1 | $0 | $75K | Oct 2, 2026 | — |
| RPeter Meijer | House · MI-03 | 1 | 0 | 1 | $0 | $32.5K | Feb 16, 2021 | — |
Recent trades
| Politician | Ticker | Asset | Type | Owner | Amount | vs S&P Estimated | Traded | Filed | Source |
|---|---|---|---|---|---|---|---|---|---|
| RThomas H. Kean, Jr. | ABT | Abbott Laboratories Common Stock (ABT) | Partial | Self | $1,001 - $15,000 | -10.0% | Sep 17, 2026 | Oct 30, 202643d | Filing |
| RPete Sessions | ABT | Abbott Laboratories Common Stock (ABT) | Sell | Spouse | $50,001 - $100,000 | -14.9% | Oct 2, 2026 | Oct 27, 202625d | Filing |
| DGilbert Ray Cisneros, Jr. | ABT | Abbott Laboratories Common Stock (ABT) | Buy | Self | $1,001 - $15,000 | +17.4% | Sep 18, 2026 | Oct 12, 202624d | Filing |
| DRo Khanna | ABT | ABBOTTLABORATORIESCMN | Buy | Spouse | $1,001 - $15,000 | +20.8% | Sep 4, 2026 | Oct 7, 202633d | FilingOCR |
| RRick W. Allen | ABT | Abbott Laboratories Common Stock (ABT) | Sell | Spouse | $15,001 - $50,000 | -5.3% | Jul 14, 2026 | Aug 18, 202635d | Filing |
| RRichard McCormick | ABT | Abbott Laboratories Common Stock (ABT) | Sell | Self | $1,001 - $15,000 | -7.7% | Jul 30, 2026 | Aug 14, 202615d | Filing |
| RMike Kelly | ABT | Abbott Laboratories Common Stock (ABT) | Sell | Spouse | $1,001 - $15,000 | -7.5% | Jul 17, 2026 | Aug 12, 202626d | Filing |
| RAlan Armstrong | ABT | Abbott Laboratories Common Stock | Sell | Self | $15,001 - $50,000 | -16.0% | Mar 27, 2026 | Jul 21, 2026116d | Filing |
| DRick Larsen | ABT | Abbott Laboratories Common Stock (ABT) | Sell | Self | $1,001 - $15,000 | -25.5% | Jul 8, 2026 | Jul 12, 20264d | Filing |
| RRichard McCormick | ABT | Abbott Laboratories Common Stock (ABT) | Buy | Self | $1,001 - $15,000 | +22.8% | Jun 12, 2026 | Jul 9, 202627d | Filing |
| RRichard McCormick | ABT | Abbott Laboratories Common Stock (ABT) | Buy | Self | $1,001 - $15,000 | +22.8% | Jun 12, 2026 | Jul 9, 202627d | Filing |
| DRo Khanna | ABT | ABBOTT LABORATORIES CMN | Buy | Spouse | $1,001 - $15,000 | +21.2% | Jun 30, 2026 | Jul 6, 20266d | FilingOCR |
| DRo Khanna | ABT | ABBOTT LABORATORIES | Sell | Dependent | $1,001 - $15,000 | -21.2% | Jun 23, 2026 | Jul 6, 202613d | FilingOCR |
| DRo Khanna | ABT | ABBOTTLABORATORIES | Sell | Dependent | $1,001 - $15,000 | -21.2% | Jun 23, 2026 | Jul 6, 202613d | FilingOCR |
| DRo Khanna | ABT | ABBOTTLABORATORIES | Sell | Spouse | $1,001 - $15,000 | -21.2% | Jun 23, 2026 | Jul 6, 202613d | FilingOCR |
| DRo Khanna | ABT | ABBOTTLABORATORIESCMN | Buy | Dependent | $1,001 - $15,000 | +21.2% | May 2, 2026 | Jul 6, 202665d | FilingOCR |
| DGilbert Ray Cisneros, Jr. | ABT | Abbott Laboratories Common Stock (ABT) | Buy | Self | $1,001 - $15,000 | +20.7% | Jun 16, 2026 | Jul 2, 202616d | Filing |
| DJulie Johnson | ABT | Abbott Laboratories Common Stock (ABT) | Sell | Joint | $1,001 - $15,000 | -30.0% | May 12, 2026 | Jun 12, 202631d | Filing |
| DRo Khanna | ABT | ABBOTT LABORATORIES CMN | Sell | Spouse | $15,001 - $50,000 | -25.0% | May 27, 2026 | Jun 9, 202613d | FilingOCR |
| DRo Khanna | ABT | ABBOTTLABORATORIESCMN | Buy | Spouse | $15,001 - $50,000 | +25.0% | May 15, 2026 | Jun 9, 202625d | FilingOCR |
| DRo Khanna | ABT | ABBOTT LABORATORIES CMN | BuyReview | Unknown | $15,001 - $50,000 | +25.0% | May 1, 2026 | Jun 9, 202639d | FilingOCR |
| DGilbert Ray Cisneros, Jr. | ABT | Abbott Laboratories Common Stock (ABT) | Sell | Self | $1,001 - $15,000 | -26.4% | May 15, 2026 | Jun 8, 202624d | Filing |
| RRick W. Allen | ABT | Abbott Laboratories Common Stock (ABT) | Sell | Spouse | $15,001 - $50,000 | -25.4% | Apr 16, 2026 | Jun 5, 202650d | Filing |
| DJosh Gottheimer | ABT | Abbott Laboratories Common Stock (ABT) | Partial | Joint | $1,001 - $15,000 | -33.4% | May 27, 2026 | Jun 3, 20267d | Filing |
| DRo Khanna | ABT | ABBOTT LABORATORIES CMN | UnknownReview | Self | $1,001 - $15,000 | — | Apr 13, 2026 | May 11, 202628d | FilingOCR |
| DLaura Friedman | ABT | Abbott Laboratories Common Stock (ABT) | Exchange | Self | $1,001 - $15,000 | — | Mar 24, 2026 | Apr 17, 202624d | Filing |
| RMichael T. McCaul | ABT | ABBOTTLABORATORIES | Sell | Spouse | $1,001 - $15,000 | -1.3% | Mar 4, 2026 | Apr 8, 202635d | FilingOCR |
| DRo Khanna | ABT | ABBOTT LABORATORIES CMN | Buy | Spouse | $15,001 - $50,000 | +0.4% | Mar 23, 2026 | Apr 7, 202615d | FilingOCR |
| RRichard McCormick | ABT | Abbott Laboratories Common Stock (ABT) | Buy | Self | $1,001 - $15,000 | +0.4% | Mar 19, 2026 | Apr 7, 202619d | Filing |
| DRo Khanna | ABT | ABBOTT LABORATORIES CMN | Buy | Spouse | $1,001 - $15,000 | +0.4% | Mar 10, 2026 | Apr 7, 202628d | FilingOCR |
| RMichael T. McCaul | ABT | ABBOTT LABORATORIES | Sell | Spouse | $15,001 - $50,000 | +5.5% | Feb 27, 2026 | Mar 10, 202611d | FilingOCR |
| RMichael T. McCaul | ABT | ABBOTT LABORATORIES | Buy | Spouse | $15,001 - $50,000 | -5.5% | Feb 5, 2026 | Mar 10, 202633d | FilingOCR |
| DRo Khanna | ABT | ABBOTT LABORATORIES CMN | Buy | Dependent | $15,001 - $50,000 | -7.2% | Feb 24, 2026 | Mar 9, 202613d | FilingOCR |
| DRo Khanna | ABT | ABBOTT LABORATORIES | Sell | Dependent | $1,001 - $15,000 | +7.2% | Feb 18, 2026 | Mar 9, 202619d | FilingOCR |
| DRo Khanna | ABT | ABBOTTLABORATORIES | Sell | Spouse | $1,001 - $15,000 | +7.2% | Feb 18, 2026 | Mar 9, 202619d | FilingOCR |
| DRo Khanna | ABT | ABBOTT LABORATORIES CMN | Sell | Spouse | $15,001 - $50,000 | +7.2% | Feb 17, 2026 | Mar 9, 202620d | FilingOCR |
| DGilbert Ray Cisneros, Jr. | ABT | Abbott Laboratories Common Stock (ABT) | Partial | Self | $1,001 - $15,000 | +7.2% | Feb 10, 2026 | Mar 9, 202627d | Filing |
| RThomas H. Kean, Jr. | ABT | Abbott Laboratories Common Stock (ABT) | Buy | Self | $1,001 - $15,000 | -5.8% | Jan 29, 2026 | Feb 19, 202621d | Filing |
| DRo Khanna | ABT | ABBOTTLABORATORIESCMN | Sell | Spouse | $15,001 - $50,000 | +3.6% | Jan 29, 2026 | Feb 6, 20268d | FilingOCR |
| DRo Khanna | ABT | ABBOTT LABORATORIES CMN | Sell | Dependent | $15,001 - $50,000 | +3.6% | Jan 23, 2026 | Feb 6, 202614d | FilingOCR |
| DRo Khanna | ABT | ABBOTTLABORATORIES CMN | Sell | Dependent | $15,001 - $50,000 | +3.6% | Jan 22, 2026 | Feb 6, 202615d | FilingOCR |
| DJulie Johnson | ABT | Abbott Laboratories Common Stock (ABT) | Sell | Joint | $1,001 - $15,000 | +13.9% | Dec 18, 2025 | Jan 15, 202628d | Filing |
| RJulia Letlow | ABT | Abbott Laboratories Common Stock (ABT) | Sell | Self | $1,001 - $15,000 | +14.3% | Dec 8, 2025 | Jan 13, 202636d | Filing |
| RJulia Letlow | ABT | Abbott Laboratories Common Stock (ABT) | Buy | Self | $1,001 - $15,000 | -14.3% | Oct 23, 2024 | Jan 13, 2026447d | Filing |
| DGilbert Ray Cisneros, Jr. | ABT | Abbott Laboratories Common Stock (ABT) | Partial | Self | $1,001 - $15,000 | +14.3% | Dec 19, 2025 | Jan 12, 202624d | Filing |
| RByron Donalds | ABT | Abbott Laboratories Common Stock (ABT) | Sell | Spouse | $1,001 - $15,000 | +16.9% | Dec 4, 2025 | Jan 7, 202634d | Filing |
| RByron Donalds | ABT | Abbott Laboratories Common Stock (ABT) | Sell | Self | $1,001 - $15,000 | +16.9% | Dec 4, 2025 | Jan 7, 202634d | Filing |
| DRo Khanna | ABT | ABBOTT LABORATORIES CMN | Buy | Dependent | $1,001 - $15,000 | -17.1% | Dec 30, 2025 | Jan 6, 20267d | FilingOCR |
| DGilbert Ray Cisneros, Jr. | ABT | Abbott Laboratories Common Stock (ABT) | Buy | Self | $1,001 - $15,000 | -19.3% | Nov 18, 2025 | Dec 15, 202527d | Filing |
| DJulie Johnson | ABT | Abbott Laboratories Common Stock (ABT) | Partial | Joint | $1,001 - $15,000 | +14.2% | Nov 13, 2025 | Dec 11, 202528d | Filing |
Insider activity Filed
Insiders
27
Pharmaceutical Preparations
Open-market buys · 90d
0
$0 bought
Open-market sells · 90d
4
$46.9M sold
Net · 90d
-$46.9M
-$43.1M net over 12 months · last Sep 30, 2026
| Date | Insider | Kind | Security | Shares | Price | Value | Post-holdings | D/I | 10b5-1 | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026filed Oct 2, 2026 | John G Stratton | Award | Stock Equivalent Unitsderiv. | 397 | $98.83 | — | 14,499 | D | — | 4 |
| Sep 30, 2026filed Oct 2, 2026 | Patricia Paola Gonzalez | Award | Stock Equivalent Unitsderiv. | 333 | $98.83 | — | 6,331 | D | — | 4 |
| Sep 30, 2026filed Oct 2, 2026 | Kevin T Conroy | Award | Stock Equivalent Unitsderiv. | 318 | $98.83 | — | 551 | D | — | 4 |
| Sep 30, 2026filed Oct 2, 2026 | Nita Ahuja | Award | Stock Equivalent Unitsderiv. | 318 | $98.83 | — | 771 | D | — | 4 |
| Sep 30, 2026filed Oct 2, 2026 | Michael F Roman | Award | Stock Equivalent Unitsderiv. | 381 | $98.83 | — | 7,166 | D | — | 4 |
| Sep 23, 2026filed Sep 25, 2026 | Kevin T Conroy | Withholding | Common shares without par value | −52,507 | $103.99 | $5,460,203 | 81,230 | D | — | 4 |
| Sep 2, 2026filed Sep 3, 2026 | John A. Mccoy Jr.VICE PRESIDENT AND CONTROLLER | Sale | Common shares without par value | −27 | $109.54 | $2,958 | 24,549 | D | — | 4 |
| Sep 1, 2026filed Sep 3, 2026 | John A. Mccoy Jr.VICE PRESIDENT AND CONTROLLER | Withholding | Common shares without par value | −52 | $110.36 | $5,739 | 24,576 | D | — | 4 |
| Sep 1, 2026filed Sep 3, 2026 | Philip P BoudreauEVP AND CFO | Withholding | Common shares without par value | −388 | $110.36 | $42,820 | 70,784 | D | — | 4 |
| Aug 25, 2026filed Aug 27, 2026 | Robert B FordCHAIRMAN AND CEO | Exercise | Option (right to buy)deriv. | −246,963 | $0.00 | — | 0 | D | — | 4 |
Shares, prices and post-transaction holdings are exactly as reported on SEC Form 4. Net figures count open-market buys minus open-market sales only (awards, exercises, withholding and gifts are excluded).
Unusual activity Estimated
- 50Insider overlapPublic Oct 30, 2026 · traded Sep 17, 2026
Rep. Thomas H. Kean, Jr. partially sold ABT 23 days after its CEO sold $25.3M
Details
- Politician
- Thomas H. Kean, Jr.
- Ticker
- ABT
- Asset
- Abbott Laboratories Common Stock (ABT)
- Tx type
- partial_sale
- Traded
- Sep 17, 2026
- Filed
- Oct 30, 2026
- Amount low
- $1,001
- Amount high
- $15,000
- Range midpoint (estimate)
- $8,001
- Disclosed range
- $1,001 - $15,000
- Reporting lag days
- 43
- Owner type
- self
- Is whale
- No
- Insider trade
- {"insider":{"slug":"robert-b-ford","name":"Robert B Ford","title":"CHAIRMAN AND CEO","short_title":"CEO"},"company":"ABBOTT LABORATORIES","ticker":"ABT","tx_kind":"open_market_sale","tx_date":"2026-08-25","shares":218535,"price":115.57,"value":25256089.95,"is_10b5_1":false,"filing_date":"2026-08-27"}
- Days between
- 23
- Opposite side
- No
- Public from
- Oct 30, 2026
- Method version
- 2026-11-03
- 28First-time tickerPublic Oct 27, 2026 · traded Oct 2, 2026
First-ever ABT trade for Rep. Pete Sessions's spouse: $50K–$100K sale
Details
- Politician
- Pete Sessions
- Ticker
- ABT
- Asset
- Abbott Laboratories Common Stock (ABT)
- Tx type
- sell
- Traded
- Oct 2, 2026
- Filed
- Oct 27, 2026
- Amount low
- $50,001
- Amount high
- $100K
- Range midpoint (estimate)
- $75,001
- Disclosed range
- $50,001 - $100,000
- Reporting lag days
- 25
- Owner type
- spouse
- Is whale
- No
- Public from
- Oct 27, 2026
- Method version
- 2026-11-03
- 65Insider overlapPublic Oct 12, 2026 · traded Sep 18, 2026
Rep. Gilbert Ray Cisneros, Jr. bought ABT 24 days after its CEO sold $25.3M
Details
- Politician
- Gilbert Ray Cisneros, Jr.
- Ticker
- ABT
- Asset
- Abbott Laboratories Common Stock (ABT)
- Tx type
- buy
- Traded
- Sep 18, 2026
- Filed
- Oct 12, 2026
- Amount low
- $1,001
- Amount high
- $15,000
- Range midpoint (estimate)
- $8,001
- Disclosed range
- $1,001 - $15,000
- Reporting lag days
- 24
- Owner type
- self
- Is whale
- No
- Insider trade
- {"insider":{"slug":"robert-b-ford","name":"Robert B Ford","title":"CHAIRMAN AND CEO","short_title":"CEO"},"company":"ABBOTT LABORATORIES","ticker":"ABT","tx_kind":"open_market_sale","tx_date":"2026-08-25","shares":218535,"price":115.57,"value":25256089.95,"is_10b5_1":false,"filing_date":"2026-08-27"}
- Days between
- 24
- Opposite side
- Yes
- Public from
- Oct 12, 2026
- Method version
- 2026-11-03
- 65Insider overlapPublic Oct 7, 2026 · traded Sep 4, 2026
Rep. Ro Khanna's spouse bought ABT 10 days after its CEO sold $25.3M
Details
- Politician
- Ro Khanna
- Ticker
- ABT
- Asset
- ABBOTTLABORATORIESCMN
- Tx type
- buy
- Traded
- Sep 4, 2026
- Filed
- Oct 7, 2026
- Amount low
- $1,001
- Amount high
- $15,000
- Range midpoint (estimate)
- $8,001
- Disclosed range
- $1,001 - $15,000
- Reporting lag days
- 33
- Owner type
- spouse
- Is whale
- No
- Insider trade
- {"insider":{"slug":"robert-b-ford","name":"Robert B Ford","title":"CHAIRMAN AND CEO","short_title":"CEO"},"company":"ABBOTT LABORATORIES","ticker":"ABT","tx_kind":"open_market_sale","tx_date":"2026-08-25","shares":218535,"price":115.57,"value":25256089.95,"is_10b5_1":false,"filing_date":"2026-08-27"}
- Days between
- 10
- Opposite side
- Yes
- Public from
- Oct 7, 2026
- Method version
- 2026-11-03
- 51Exec salePublic Aug 27, 2026 · traded Aug 25, 2026
ABT CEO Robert B Ford sold $25.3M
Details
- Insider
- Robert B Ford
- Company
- ABBOTT LABORATORIES
- Ticker
- ABT
- Tx kind
- open_market_sale
- Traded
- Aug 25, 2026
- Shares
- 218,535
- Price
- $116
- Value
- $25.3M
- Is 10b5 1
- No
- Filed
- Aug 27, 2026
- Public from
- Aug 27, 2026
- Method version
- 2026-11-03
- 50Insider overlapPublic Aug 27, 2026 · traded Jul 30, 2026
Rep. Richard McCormick sold ABT 26 days before its CEO sold $25.3M
Details
- Politician
- Richard McCormick
- Ticker
- ABT
- Asset
- Abbott Laboratories Common Stock (ABT)
- Tx type
- sell
- Traded
- Jul 30, 2026
- Filed
- Aug 14, 2026
- Amount low
- $1,001
- Amount high
- $15,000
- Range midpoint (estimate)
- $8,001
- Disclosed range
- $1,001 - $15,000
- Reporting lag days
- 15
- Owner type
- self
- Is whale
- No
- Insider trade
- {"insider":{"slug":"robert-b-ford","name":"Robert B Ford","title":"CHAIRMAN AND CEO","short_title":"CEO"},"company":"ABBOTT LABORATORIES","ticker":"ABT","tx_kind":"open_market_sale","tx_date":"2026-08-25","shares":218535,"price":115.57,"value":25256089.95,"is_10b5_1":false,"filing_date":"2026-08-27"}
- Days between
- -26
- Opposite side
- No
- Public from
- Aug 27, 2026
- Method version
- 2026-11-03
- 49Exec salePublic Aug 27, 2026 · traded Aug 25, 2026
ABT CEO Robert B Ford sold $20.9M
Details
- Insider
- Robert B Ford
- Company
- ABBOTT LABORATORIES
- Ticker
- ABT
- Tx kind
- open_market_sale
- Traded
- Aug 25, 2026
- Shares
- 180,297
- Price
- $116
- Value
- $20.9M
- Is 10b5 1
- No
- Filed
- Aug 27, 2026
- Public from
- Aug 27, 2026
- Method version
- 2026-11-03
- 43Committee overlapPublic Aug 18, 2026 · traded Jul 14, 2026
Rep. Rick W. Allen's spouse sold $15,001–$50,000 of ABT; Rep. Rick W. Allen sits on House Energy and Commerce
Details
- Committee
- House Committee on Energy and Commerce
- Leadership seat
- No
- Sector
- Healthcare
- Disclosed range
- $15,001 - $50,000
- Traded
- Jul 14, 2026
- Filed
- Aug 18, 2026
- Public from
- Aug 18, 2026
- Method version
- 2026-11-03
- 30Cluster sellPublic Aug 18, 2026 · traded Jul 8, 2026
3 members sold ABT within 14 days
Details
- Ticker
- ABT
- Side
- sell
- Window days
- 14
- Window start
- Jul 8, 2026
- Window end
- Jul 17, 2026
- N politicians
- 3
- N trades
- 3
- Sum of range midpoints (estimate)
- $48,502
- Has whale
- No
- Members
- Rick Larsen, Rick W. Allen, Mike Kelly
- Tx ids
- 86,236, 85,822, 85,883
- Public from
- Aug 18, 2026
- Method version
- 2026-11-03
- 47Hindsight movePublic Aug 12, 2026 · traded Jun 30, 2026
ABT rose 22% in the 30 trading days after Rep. Ro Khanna's spouse's buy (hindsight)
Details
- Politician
- Ro Khanna
- Ticker
- ABT
- Asset
- ABBOTT LABORATORIES CMN
- Tx type
- buy
- Traded
- Jun 30, 2026
- Filed
- Jul 6, 2026
- Amount low
- $1,001
- Amount high
- $15,000
- Range midpoint (estimate)
- $8,001
- Disclosed range
- $1,001 - $15,000
- Reporting lag days
- 6
- Owner type
- spouse
- Is whale
- No
- Entry date
- Jun 30, 2026
- Entry close
- 90.74
- Exit date
- Aug 12, 2026
- Exit close
- 110.91
- Forward return
- +22.2%
- Sign adjusted return
- +22.2%
- N trading days
- 30
- Hindsight
- Yes
- Measured from
- trade date
- Public from
- Aug 12, 2026
- Method version
- 2026-11-03